Free Trial
NYSEAMERICAN:AST

Asterias Biotherapeutics (AST) Stock Price, News & Analysis

Asterias Biotherapeutics logo
$0.0020 0.00 (0.00%)
As of 07/10/2019

About Asterias Biotherapeutics Stock (NYSEAMERICAN:AST)

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
N/A
52-Week Range
$0.51
$2.05
Volume
1,000 shs
Average Volume
136,653 shs
Market Capitalization
$111.32 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asterias Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

AST Stock News Headlines

ARTV Artiva Biotherapeutics, Inc.
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
CLDI Calidi Biotherapeutics, Inc.
Protalix BioTherapeutics Inc PLX
See More Headlines

AST Stock Analysis - Frequently Asked Questions

Asterias Biotherapeutics' stock was trading at $0.0020 at the beginning of 2025. Since then, AST shares have increased by 0.0% and is now trading at $0.0020.

Asterias Biotherapeutics Inc (NYSEAMERICAN:AST) posted its quarterly earnings data on Tuesday, March, 28th. The biotechnology company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The biotechnology company had revenue of $1.75 million for the quarter, compared to analysts' expectations of $2.81 million.

Shares of AST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asterias Biotherapeutics investors own include Zynerba Pharmaceuticals (ZYNE), CorMedix (CRMD), Synergy Pharmaceuticals (SGYP), 22nd Century Group (XXII), Amarin (AMRN), Gilead Sciences (GILD) and Progenics Pharmaceuticals (PGNX).

Company Calendar

Last Earnings
3/28/2017
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:AST
Previous Symbol
NYSEMKT:AST
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$111.32 thousand
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSEAMERICAN:AST) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners